TheraCann announces business combination agreement with Trusted Brand 2016 Inc.
Our cannabis industry partner and exclusive licensee of our taggant platform to that industry, TheraCann, announced yesterday its intention to list on the TSX-V via a merger with a listed company.
Cannabis represents a substantial addressable market for both TheraCann and Applied DNA going forward and our two companies are working closely together to build a robust pipeline of sales opportunities that will generate purchase orders to Applied DNA. Applied DNA also looks forward to the receipt of a final $4.0 million from TheraCann under the licensing agreement by August 15, 2019.
I invite you to listen TheraCann CEO Jason Warnock’s recent presentation at our annual meeting of shareholders. Hear from Jason himself of the opportunities ahead for both our companies. Please click through the link below.